Ann: Uscom to present at NWR Communications Virtual Investor Conf, page-3

Walls and walls of sellers building as seems normal newb. Buying support is terrible.
Other than its every 2 year quick spikes that have never been sustainable it’s been terribly disappointing since 2009 when it had the great contract and early sales success with spacelabs .
Has been reinvesting its 1a sales back into itself for 10 years developing new products and overseas offices but my take is the market feels finding new hospitals for future 1a sales in large numbers needed to maintain or increase these sales compared to the past won’t happen.
Not sure how many 1a sales a year it’s going to need to achieve the $8 - $10 mill receipts / revenues a year the market is craving to start giving the company the love it deserves for persistence. The sellers are betting it won’t happen in the numbers required anytime soon .
Hoping some large bp plus - spirosonic or ventitest revenues will start to contribute in significant $ very very soon.
Trying to stay confident based on fundamentals and due to the great products and there life saving and life changing abilities but it’s time the 10 year build in itself starts to really appreciate with strong sales and profitability.